CLS Holdings USA (XCNQ:CLSH) FCF Margin % : -3.81% (As of Feb. 2025)

View and export this data going back to 2019. Start your Free Trial

What is CLS Holdings USA FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. CLS Holdings USA's Free Cash Flow for the three months ended in Feb. 2025 was C$-0.21 Mil. CLS Holdings USA's Revenue for the three months ended in Feb. 2025 was C$5.51 Mil. Therefore, CLS Holdings USA's FCF Margin % for the quarter that ended in Feb. 2025 was -3.81%.

As of today, CLS Holdings USA's current FCF Yield % is 8.15%.

The historical rank and industry rank for CLS Holdings USA's FCF Margin % or its related term are showing as below:

XCNQ:CLSH' s FCF Margin % Range Over the Past 10 Years
Min: -132.43 Med: -16.67 Max: 3.31
Current: 2.71

During the past 12 years, the highest FCF Margin % of CLS Holdings USA was 3.31%. The lowest was -132.43%. And the median was -16.67%.

XCNQ:CLSH's FCF Margin % is ranked better than
55.62% of 969 companies
in the Drug Manufacturers industry
Industry Median: 0.94 vs XCNQ:CLSH: 2.71

CLS Holdings USA FCF Margin % Historical Data

The historical data trend for CLS Holdings USA's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CLS Holdings USA FCF Margin % Chart

CLS Holdings USA Annual Data

Trend

May15

May16

May17

May18

May19

May20

May21

May22

May23

May24

FCF Margin %

Get a 7-Day Free Trial

-42.86

-14.53

-18.81

-1.65

3.31

CLS Holdings USA Quarterly Data
	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
FCF Margin %	Get a 7-Day Free Trial															-8.23	3.45	5.24	5.19	-3.81

Competitive Comparison of CLS Holdings USA's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, CLS Holdings USA's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CLS Holdings USA's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CLS Holdings USA's FCF Margin % distribution charts can be found below:

* The bar in red indicates where CLS Holdings USA's FCF Margin % falls into.

Save Embed

;

Save Embed

;

CLS Holdings USA FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

CLS Holdings USA's FCF Margin for the fiscal year that ended in May. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: May. 2024 )	/	Revenue (A: May. 2024 )
	=	0.904	/	27.281
	=	3.31 %

CLS Holdings USA's FCF Margin for the quarter that ended in Feb. 2025 is calculated as

FCF Margin	=	Free Cash Flow (Q: Feb. 2025 )	/	Revenue (Q: Feb. 2025 )
	=	-0.21	/	5.512
	=	-3.81 %

CLS Holdings USA FCF Margin % Related Terms

Thank you for viewing the detailed overview of CLS Holdings USA's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

CLS Holdings USA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CLS Holdings USA Inc (XCNQ:CLSH) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

CLSH:USA

Address

516 South, 4th Street, Las Vegas, NV, USA, 89101

Website

https://www.clsholdingsinc.com

CLS Holdings USA Inc is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for Cannabis Life Sciences in recognition of the company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. The company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products.

Executives

Todd Swanson

10% Security Holder